MediBIC Group (2369.T)

2369.T on Tokyo Stock Exchange

6,500JPY
22 Dec 2009
Price Change (% chg)

¥-220 (-3.27%)
Prev Close
¥6,500
Open
--
Day's High
¥6,720
Day's Low
¥6,440
Volume
140
Avg. Vol
299
52-wk High
¥12,000
52-wk Low
¥5,620

2369.T

Chart for 2369.T

About

MediBIC Group is a Japan-based company comprised of five business segments. The Biomarker Drug Discovery segment provides support solution services for new drug development, including the provision of analytical, clinical trial coordinate, data analytical and pharmacogenomics (PGx) test support services, as well as the sale of... (more)
No analyst recommendations are available for 2369.T.

Overall

Beta: 1.14
Market Cap (Mil.): ¥1,184.33
Shares Outstanding (Mil.): 0.18
Annual Dividend: --
Yield (%): --

Financials

  2369.T Industry Sector
P/E (TTM): -- 12.69 4.64
EPS (TTM): -- -- --
ROI: -- 1.36 2.82
ROE: -- 2.20 3.58
view overview for:

TABLE-MediBic Group <2369.T>-9-mth group results

9 months ended 9 months ended Year to

12 Nov 2009

TABLE-MediBic Group <2369.T>-6mth group results

6 months ended 6 months ended Full year to Full year ended

13 Aug 2009

MediBic Group <2369.T>-1qtr group results

3 months ended 3 months ended 6 months to Year to

13 May 2009

Toshiba, Canon, others to team up on biochips

TOKYO (Reuters) - Toshiba Corp , Canon Inc and 30 to 40 other Japanese firms will team up to develop biochips, seeking new revenues in a market currently dominated by U.S. firms.

26 Sep 2007

  Earnings  vs    Estimates

view overview for: